Zuclopenthixol acetate for acute schizophrenia and similar major mental illnesses.

Jayakody K, Chuang S, Gunadasa S, Gibson RC, Kumar A, Tune P

Open source

DOI
10.1002/14651858.cd000525.pub4
Published
2026 Sep 24
Container
The Cochrane database of systematic reviews
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd000525.pub4,
  title = {Zuclopenthixol acetate for acute schizophrenia and similar major mental illnesses.},
  author = {Jayakody K and Chuang S and Gunadasa S and Gibson RC and Kumar A and Tune P},
  year = {2026},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd000525.pub4},
  url = {https://doi.org/10.1002/14651858.cd000525.pub4}
}

RIS

TY  - JOUR
TI  - Zuclopenthixol acetate for acute schizophrenia and similar major mental illnesses.
AU  - Jayakody K
AU  - Chuang S
AU  - Gunadasa S
AU  - Gibson RC
AU  - Kumar A
AU  - Tune P
PY  - 2026
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd000525.pub4
UR  - https://doi.org/10.1002/14651858.cd000525.pub4
ER  - 

APA

K, J., S, C., S, G., RC, G., A, K., & P, T. (2026). Zuclopenthixol acetate for acute schizophrenia and similar major mental illnesses.. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd000525.pub4

Source records